Skip to main content Accessibility help
×
Home

Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test

  • S. B. HAN (a1) (a2), K. R. KANG (a2), D. H. HUH (a2), H. C. LEE (a2), J. H. KIM (a1) (a2), J. H. KANG (a1) (a2) and S. H. MA (a3)...

Summary

We conducted a cross-sectional seroepidemiological study in 2012–2013 to determine the seroprevalence of varicella-zoster virus (VZV) in adolescents and adults living in Korea, where varicella vaccination has been recommended universally at age 12–15 months since 2005. Residual serum samples were collected from 1196 healthy adults and adolescents aged ⩾10 years between November 2012 and March 2013. The fluorescent antibody to membrane antigen (FAMA) test and enzyme-linked immunosorbent assay (ELISA) were performed to determine the seroprevalence of VZV. The seroprevalences of VZV were compared between six age groups: 10–19, 20–29, 30–39, 40–49, 50–59, and ⩾60 years. The seroprevalence of VZV in the entire study cohort was 99·1% according to the FAMA test and 93·1% as determined by ELISA. The seroprevalences of the six age groups were as follows: 96·0%, 99·5%, 99·5%, 99·5%, 100%, and 100%, respectively, by the FAMA test, and 83·3%, 93·0%, 93·0%, 97·5%, 94·5%, and 97·5%, respectively, by ELISA. Seroprevalence increased significantly with age (P < 0·001); moreover, the seroprevalence in subjects aged 10–19 years was significantly lower than in other age groups (P < 0·001), as measured by both the FAMA test and ELISA. Thus, strategies to increase protective immunity against VZV in teenagers are necessary.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test
      Available formats
      ×

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corresponding author

* Author for correspondence: Professor J. H. Kang, Department of Pediatrics, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 137-701, Republic of Korea. (Email: kjhan@catholic.ac.kr)

References

Hide All
1. Arvin, AM. Varicella-zoster virus. Clinical Microbiology Reviews 1996; 9: 361381.
2. Hambleton, S, Gershon, AA. Preventing varicella-zoster disease. Clinical Microbiology Reviews 2005; 18: 7080.
3. Tang, H, et al. A community-based survey of varicella-zoster virus-specific immune responses in the elderly. Journal of Clinical Virology 2012; 55: 4650.
4. Gershon, AA, Gershon, MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clinical Microbiology Reviews 2013; 26: 728743.
5. Berger, R, Florent, G, Just, M. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infection and Immunity 1981; 32: 2427.
6. Choi, WS, et al. Immunity and the burden of herpes zoster. Journal of Medical Virology 2014; 86: 525530.
7. Choi, WS, et al. Disease burden of herpes zoster in Korea. Journal of Clinical Virology 2010; 47: 325329.
8. Korean Statistical Information Service. (http://kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parentId=A). Accessed 1 May 2014.
9. Korean Network for Organ Sharing. (http://www.konos.go.kr/konosis/common/bizlogic.jsp). Accessed 1 May 2014.
10. Jin, DC. Current status of dialysis therapy in Korea. Korean Journal of Internal Medicine 2011; 26: 123131.
11. Park Ie, B, et al. Diabetes epidemics in Korea: reappraise nationwide survey of diabetes ‘diabetes in Korea 2007’. Diabetes & Metabolism Journal 2013; 37: 233239.
12. Kawai, K, Gebremeskel, BG, Acosta, CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 2014; 4: e004833.
13. Jo, DS, et al. Recommended immunization schedule for children and adolescents: the Korean Pediatric Society, 2013. Korean Journal of Pediatrics 2013; 56: 231234.
14. Park, B, et al. Estimation of nationwide vaccination coverage and comparison of interview and telephone survey methodology for estimating vaccination status. Journal of Korean Medical Science 2011; 26: 711719.
15. Brisson, M, et al. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20: 25002507.
16. Reynolds, MA, et al. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. Journal of Infectious Diseases 2008 ; 197 (Suppl. 2): S224227.
17. Huang, WC, et al. Varicella breakthrough infection and vaccine effectiveness in Taiwan. Vaccine 2011; 29: 27562760.
18. Chaves, SS, et al. Loss of vaccine-induced immunity to varicella over time. New England Journal of Medicine 2007; 356: 11211129.
19. Tugwell, BD, et al. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 2004; 113: 455459.
20. Choi, WS, et al. Seroprevalence of varicella-zoster virus in Korea. Journal of Medical Virology 2010; 82: 21232126.
21. Kim, YH, et al. Seroepidemiologic survey of varicella-zoster virus in korean adults using glycoprotein enzyme immunoassay and fluorescent antibody to membrane antigen test. Annals of Dermatology 2011; 23: 3943.
22. Lee, H, Cho, HK, Kim, KH. Seroepidemiology of varicella-zoster virus in Korea. Journal of Korean Medical Science 2013; 28: 195199.
23. Larussa, P, et al. Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test. Journal of Clinical Microbiology 1987; 25: 20592062.
24. Steinberg, SP, Gershon, AA. Measurement of antibodies to varicella-zoster virus by using a latex agglutination test. Journal of Clinical Microbiology 1991; 29: 15271529.
25. Saiman, L, et al. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers. Infection Control and Hospital Epidemiology 2001; 22: 279283.
26. Rolando, L, et al. Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days. Infection Control and Hospital Epidemiology 2010; 31: 972974.
27. Kim, SH, et al. Seroprevalence rate after one dose of varicella vaccine in infants. Journal of Infection 2010; 61: 6672.
28. Breuer, J, Schmid, DS, Gershon, AA. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. Journal of Infectious Diseases 2008; 197 (Suppl. 2): S147151.
29. Williams, V, Gershon, A, Brunell, PA. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. Journal of Infectious Diseases 1974; 130: 669672.
30. Sauerbrei, A, et al. Immune response of varicella vaccinees to different varicella-zoster virus genotypes. Vaccine 2011; 29: 38733877.
31. Li, T-C, Rutherford, I. Comparison of two commercial enzyme-linked immunosorbent assays and fluorescent antibody to membrane antigen test for immune status to Varicella Zoster virus. Serodiagnosis and Immunotherapy in Infectius Disease 1988; 2: 395399.
32. Petrie, A, Sabin, C. Medical Statistics at a Glance, 3rd edn. Oxford: Wiley-Blackwell, 2009, pp. 118121.
33. Sauerbrei, A, et al. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test. Journal of Virological Methods 2004; 119: 2530.
34. Gallo, D, Schmidt, NJ. Comparison of anticomplement immunofluorescence and fluorescent antibody-to-membrane antigen tests for determination of immunity status to varicella-zoster virus and for serodifferentiation of varicella-zoster and herpes simplex virus infections. Journal of Clinical Microbiology 1981; 14: 539543.
35. Wutzler, P, et al. Seroprevalence of varicella-zoster virus in the German population. Vaccine 2001; 20: 121124.
36. Kim, JI, et al. Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax. Virology Journal 2011; 8: 547.
37. Kim, YH, et al. Evaluation of a commercial glycoprotein enzyme-linked immunosorbent assay for measuring vaccine immunity to varicella. Yonsei Medical Journal 2014; 55: 459466.
38. Jumaan, AO, et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002. Journal of Infectious Diseases 2005; 191: 20022007.
39. Choung, JM, et al. Study on vaccination state in children: Jeonbuk province, 2000. Journal of Korean Pediatric Society 2002; 45: 12341240.
40. Marin, M, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. Recommendations and Reports 2007; 56: 140.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed